Clinical trials

  • talazoparib for Urothelial carcinoma | Locally advanced or metastatic urothelial carcinoma
  • DEUCRICTIBANT for Hereditary angioedema
  • NIVOLUMAB for Cutaneous squamous cell carcinoma
  • ANAKINRA for Kawasaki disease
  • 10-1074-LS for HIV-1 infection|HIV
  • OBINUTUZUMAB for Lupus nephritis | Systemic lupus erythematosus (renal involvement)
  • LEVETIRACETAM for Down syndrome | Alzheimer's disease
  • Platelet concentrate | Autologous microfat for Radiocarpal osteoarthritis
  • BELANTAMAB MAFODOTIN for Relapsed/refractory multiple myeloma
  • ATEZOLIZUMAB for Triple-negative breast cancer
  • VENETOCLAX for Acute myeloid leukaemia | Favourable-risk acute myeloid leukaemia
  • BGB-16673 for Relapsed or Refractory B-cell malignancies | Diffuse large B-cell lymphoma | Follicular lymphoma | Chronic lymphocytic leukemia | Mantle cell lymphoma | Marginal zone lymphoma | Waldenström macroglobulinaemia | Richter's syndrome